Blair Brettmann received her B.S. in chemical engineering at the University of Texas at Austin in 2007. She received her Master’s in chemical engineering practice from MIT in 2009 following internships at GlaxoSmithKline (Upper Merion, PA) and Mawana Sugar Works (Mawana, India). Blair received her Ph.D. in chemical engineering at MIT in 2012 working with the Novartis-MIT Center for Continuous Manufacturing under Professor Bernhardt Trout. Her research focused on solid-state characterization and application of pharmaceutical formulations prepared by electrospinning. Following her Ph.D., Brettmann worked as a research engineer for Saint-Gobain Ceramics and Plastics for two years. While at Saint-Gobain she worked on polymer-based wet coatings and dispersions for various applications, including window films, glass fiber mats and architectural fabrics. Later, Brettmann served as a postdoctoral researcher in the Institute for Molecular Engineering at the University of Chicago with Professor Matthew Tirrell. Currently, Brettmann is an assistant professor with joint appointments in chemical and biomolecular engineering and Materials Science and Engineering at Georgia Tech.

Dr. Boukouvala is originally from Piraeus, which is the port of Athens in Greece. As the daughter of an airforce pilot, she travelled a lot with her family. Her first international move was actually to the USA, where she spent one year in Montgomery, Alabama. She later on lived in Riyadh, Saudi Arabia and Crete, Greece, before returning to Athens to get her B.S Degree in Chemical Engineering from the National Technical University in Athens. In 2008, she moved back to the US to obtain a PhD in Chemical Engineering at Rutgers University in NJ. She then worked as a Postdoctoral Associate in both Princeton University and Texas A&M University. In August 2016, Dr. Boukouvala returned to the South East US, as an Assistant Professor in the School of Chemical & Biomolecular Engineering at Georgia Tech. 

Her research interest in Process Systems Engineering (PSE) started during her PhD years, where she worked under the supervision of Dr. Marianthi Ierapetritou, on modeling and optimization of continuous pharmaceutical manufacturing. Her background on optimization and data-driven modeling was enhanced during her years as a postdoc with the late Christodoulos A. Floudas. Dr. Boukouvala is a proud 4th generation member of the academic family tree of the father of PSE, Roger Sargent.

Andreas (Andy) S. Bommarius is a professor of Chemical and Biomolecular Engineering as well of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, GA.  He received his diploma in Chemistry in 1984 at the Technical University of Munich, Germany and his Chemical Engineering B.S. and Ph.D. degrees in 1982 and 1989 at MIT, Cambridge, MA.

From 1990-2000, he led the Laboratory of Enzyme Catalysis at Degussa (now Evonik) in Wolfgang, Germany, where his work ranged from immobilizing homogenous catalysts in membrane reactors to large-scale cofactor-regenerated redox reactions to pharma intermediates.

At Georgia Tech since 2000, his research interests cover green chemistry and biomolecular engineering, specifically biocatalyst development and protein stability studies.  His lab applies data-driven protein engineering to improve protein properties on catalysts ranging from ene and nitro reductases to cellobiohydrolases.  Bommarius has guided the repositioning of the curriculum towards Chemical and Biomolecular Engineering by developing new courses in Process Design, Biocatalysis and Metabolic Engineering, as well as Drug Design, Development, and Delivery (D4), an interdisciplinary course with Mark Prausnitz.

Andy Bommarius in 2008 became a Fellow of the American Institute of Medical and Biological Engineering.  Since 2010, he is Director of the NSF-I/UCR Center for Pharmaceutical Development (CPD), a Center focusing on process development, drug substance and product stability, and novel analytical methods for the characterization of drug substances and excipients.

Saad Bhamla studies biomechanics across species to engineer knowledge and tools that inspire curiosity.

Saad Bhamla is an assistant professor of biomolecular engineering at Georgia Tech. A self-proclaimed "tinkerer," his lab is a trove of discoveries and inventions that span biology, physics and engineering. His current projects include studying the hydrodynamics of insect urine, worm blob locomotion and ultra-low-cost devices for global health. His work has appeared in the New York Times, the Economist, CNN, Wired, NPR, the Wall Street Journal and more.

Saad is a prolific inventor and his most notable inventions includes a 20-cent paper centrifuge, a 23-cent electroporator, and the 96-cent hearing aid. Saad's work is recognised by numerous awards including a NIH R35 Outstanding Investigator Award, NSF CAREER Award, CTL/BP Junior Faculty Teaching Excellence Award, and INDEX: Design to Improve Life Award. Saad is also a National Geographic Explorer and a TED speaker. Newsweek recognized Saad as 1 of 10 Innovators disrupting healthcare.

Saad is a co-founder of Piezo Therapeutics.

Outside of the lab, Saad loves to go hiking with his partner and two dogs (Ollie and Bella).

Dr. Aidun joined the Woodruff School as a Professor in 2003 after completion of a two-year period as program director at the National Science Foundation. He began at Tech in 1988 as an Assistant Professor at the Institute of Paper Science and Technology. Prior, he was a research Scientist at Battelle Research Laboratories, Postdoctoral Associate at Cornell University and Senior Research Consultant at the National Science Foundation's Supercomputer Center at Cornell. 

Dr. Aidun's research is at the intersection between fundamentals of the physics of complex fluids/thermal transport and applications to engineering and biotransport. He has a diverse research portfolio in fluid mechanics, bioengineering, renewable bioproducts and decarbonization of industrial processes. 

A major focus has been to understand the physics of blood cell transport and interaction with glycoproteins (e.g., vWF) with applications to cardiovascular diseases.